Chemerin as a marker of subclinical cardiac involvement in psoriatic patients


Aksu F., ÇALIŞKAN M. , Keles N., Toprak A. E. , Uzuncakmak T. K. , Kostek O., et al.

CARDIOLOGY JOURNAL, cilt.24, ss.276-283, 2017 (SCI İndekslerine Giren Dergi)

  • Cilt numarası: 24 Konu: 3
  • Basım Tarihi: 2017
  • Doi Numarası: 10.5603/cj.a2017.0031
  • Dergi Adı: CARDIOLOGY JOURNAL
  • Sayfa Sayısı: ss.276-283

Özet

Background: Chemerin has been associated with psoriasis and inflammation, but there are no studies demonstrating an association between chemerin and subclinical cardiac involvement in psoriatic patients. Therefore, the present study aimed to evaluate whether psoriatic patients with increased epicardial fat tissue, impaired flow-mediated dilatation, and diastolic dysfunction have higher serum chemerin levels than a healthy control group.